Our Goal of a Non-Invasive Prickless Blood Glucose Level Monitor is Within Reach
5,000 Americans will be digonsed with Diabetes
Diabetes will cost America $476 Million
in the next 24 hours alone.
7 million Americans
woke up with Diabetes and they do not know it
79 million U.S. citizens have prediabetes.
Diabetes is the leading cause of kidney
failure, nontraumatic lower limb amputations, and new cases of blindness among adults in the United States.
In 2010 there were 230,000 deaths in the
U.S. in which diabetes appeared as any-listed
cause of death.
In 2011, the estimated diabetes costs in the
U.S. totaled $218 billion which includes direct
medical costs and indirect costs including disability, work loss, and premature mortality.
Due to the fact the finger prick device is the
only cost effective SMBG device available today, it is reported that only a 33% testing
compliance rate is achieved.
 Diabetes Care August 2001 24: 1502-1503
Alethus, Inc., a Cambridge, MA based company, is developing the world's first noninvasive device for diabetes patients to monitor their glucose level in a bloodless and painless manner This will allow diabetics to measure their glucose levels as many times as they want to each and every day without pricking their finger once. Self-monitoring of blood glucose levels is crucial to glycemic control and to reduce or avoid complications.